Amgen Inc. closed 16.06% short of its 52-week high of $346.85, which the company reached on July 25th.

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...

Citi analyst Geoff Meacham maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $295.00. The company’s ...

Talk about wealth-generating powerhouses — a handful of S&P 500 companies now pull in at least $10,000 a second in revenue.

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Bristol-Myers Squibb (BMY – Research Report).

Palantir Technologies (NASDAQ: PLTR) and Tesla (NASDAQ: TSLA) were two of the most popular stocks among retail investors last ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

and Neupogen (white blood cell stimulant). Amgen successfully launched two next-generation products, Aranesp and Neulasta. Meanwhile, the acquisition of Immunex Corporation gave Amgen access to ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be complicated.

"At the end of the week, you will be an entirely different person," the trailer for Season 3 of "The White Lotus" begins. The trailer, which debuted on Jan. 27, shows groups of guests drinking ...

As the writer behind this guide to the best white sneakers, it’s fascinating ... Is there a large logo on a side that lets everyone know these are Nikes? Do they have a chunky, in-your-face ...

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Amgen's market standing. Stay informed and make well-considered decisions with our ...